Patents by Inventor Marc Janier

Marc Janier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
    Patent number: 9623127
    Abstract: A multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging.
    Type: Grant
    Filed: November 8, 2011
    Date of Patent: April 18, 2017
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, HOSPICES CIVILS DE LYON, UNIVERSITE DE STRASBOURG, UNIVERSITE CLAUDE BERNARD LYON 1
    Inventors: Delphine Felder-Flesch, Claire Billotey, Giuseppe Lamanna, Marc Janier, David Kriza
  • DENDRITIC COMPOUNDS INCLUDING A CHELATING, FLUOROCHROME OR RECOGNITION AGENT, COMPOSITIONS INCLUDING SAME AND USES THEREOF
    Publication number: 20160221992
    Abstract: The invention relates to dendritic compounds comprising a chelating, fluorochrome or recognition agent of formula (I), to compositions comprising same, and to uses thereof, wherein in said formula (I): T, L1, D, R, L2, V and n are as defined in the description.
    Type: Application
    Filed: May 16, 2014
    Publication date: August 4, 2016
    Inventors: Delphine FELDER-FLESCH, Claire BILLOTEY, Audrey PARAT, Antonio GAROFALO, David KRYZA, Marc JANIER
  • MULTIMODAL CONTRAST AND RADIOPHARMACEUTICAL AGENT FOR AN IMAGING AND A TARGETED THERAPY GUIDED BY IMAGING
    Publication number: 20140336368
    Abstract: A multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging.
    Type: Application
    Filed: November 18, 2011
    Publication date: November 13, 2014
    Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE STRASBOURG, HOSPICES CIVILS DE LYON
    Inventors: Delphine Felder-Flesch, Claire Billotey, Giuseppe Lamanna, Marc Janier, David Kriza
  • USE OF LANTHANIDE-BASED NANOPARTICLES AS RADIOSENSITIZING AGENTS
    Publication number: 20110027375
    Abstract: The invention relates to the use of nanoparticles with dimensions comprised between 1 and 50 nm, at least one portion of which consists of at least one oxide and/or one oxohydroxide of at least one lanthanide, said nanoparticles: either consisting of at least one oxide and/or one oxohydroxide of at least one lanthanide, or in the form of nanoparticles comprising a core consisting of at least one oxide and/or one oxohydroxide of at least one lanthanide, and a coating consisting of polysiloxane, with possibly organic molecules grafted at the surface or comprised inside it, as a radio-sensitizing agent in the making of an injectable composition intended to improve the efficiency of the treatment of a tumor by X or gamma irradiations.
    Type: Application
    Filed: October 14, 2008
    Publication date: February 3, 2011
    Inventors: Olivier Tillement, Stéphane Roux, Pascal Perriat, Géraldine Leduc, Céline Mandon, Brice Mutelet, Christophe Alric, Claire Billotey, Marc Janier, Cédric Louis